Remove Epilepsy Remove Events Remove Food Remove Treatment
article thumbnail

Marinus Pharmaceuticals Reports Topline Ganaxolone Phase 2 Open-Label Results in Tuberous Sclerosis Complex and Receives FDA Orphan Drug Designation

Cannabis Law Report

Food and Drug Administration (FDA) has granted orphan drug designation to ganaxolone in TSC. We look forward to initiating our Phase 3 trial and adding to the body of evidence that supports ganaxolone’s potential as an innovative treatment option for rare epilepsies.”. Conference call and webcast to be held today at 4:30 p.m.

article thumbnail

BBC Report: EU Approves , “Epidyolex” GW Pharmaceuticals

Cannabis Law Report

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. What about other medical cannabis products? PDF Version.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA Cites Five Companies for Illegally Selling Delta-8 THC and CBD Products

Cannabis Law Report

Food & Drug Administration (FDA) recently issued Warning Letters to five companies selling products containing delta-8 tetrahydrocannabinol (delta-8 THC) and cannabidiol (CBD). 2 In the recently issued Warning Letters, FDA similarly asserts delta-8 THC cannot be sold as a food. [co-author: Rachel Buff]. Martin Hahn. Background.

THC 52
article thumbnail

How is Cannabis Improving the Eating Lifestyle of People Around the World?

Otherside Farms

The newest food trend around the globe is an increase in beverages and foods containing cannabidiol, the chemical compound found in cannabis plants. The Food and Drug Administration allows the use of CBD to treat pain, anxiety, depression, nausea, and some types of epilepsy. The trend of CBD infused foods is on the rise.

Food 52
article thumbnail

And Here We Go Again! NASDAQ Article: Forget Cannabis: Psychedelic Medicine Is the Better Investing Opportunity

Cannabis Law Report

Food and Drug Administration (FDA) granted Breakthrough Therapy designation (BTD) to Compass Pathways ‘ psilocybin therapy for treatment-resistant depression. This renewed interest in psychedelics is being sparked by a pair of seemingly unrelated events. Then, something strange happened. In 2018, the U.S.

article thumbnail

7 Points On How CBD Can Help Promote Mental Health

The Joint Blog

Hence, CBD is an enticing choice for those looking for pain relief and treatments that lack the mind-altering impact of cannabis or the additional adverse effects associated with some pharmaceutical medicines. Symptoms include: Reliving traumatic events. The advantages of CBD in the treatment of schizophrenia are not well understood.

CBD 41
article thumbnail

TSA (Sort of) Allows (Some) Hemp-CBD Products on Flights

Canna Law Blog

Accordingly, TSA security officers do not search for marijuana or other illegal drugs, but in the event a substance that appears to be marijuana or a cannabis infused product is observed during security screening, TSA will refer the matter to a law enforcement officer.”. Department of Agriculture.

Hemp 78